Research Topics
| Emanuele NicastriSummaryAffiliation: National Institute for Infectious Diseases Country: Italy Publications
| Collaborators
|
Detail Information
Publications
Leishmania infantum leishmaniasis in corticosteroid--treated patientsSilvia Pittalis
National Institute for Infectious Diseases IRCCS L, Spallanzani Rome Italy
BMC Infect Dis 6:177. 2006..Immunosuppression related to HIV infection, immunosuppressive treatment, organ transplantation, and neoplastic diseases increases the risk for Leishmania-infected people to develop visceral illness...
Surgical site infections in Italian Hospitals: a prospective multicenter studyNicola Petrosillo
2nd Infectious Diseases Division, National Institute for Infectious Diseases L, Spallanzani, Via Portuense, 292 00149 Rome, Italy
BMC Infect Dis 8:34. 2008..A national prospective multicenter study was conducted with the aim of assessing the incidence of both in-hospital and postdisharge SSI, and the associated risk factors...
Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: a systematic reviewEmanuele Nicastri
National Institute for Infectious Diseases, IRCCS Lazzaro Spallanzani, Rome, Italy
J Antimicrob Chemother 60:724-32. 2007..Studies of possible differences between men and women in the course of HIV infection give conflicting results. The objective of this study was to assess sex differences during HAART...
Plasmodium falciparum multiple infections, disease severity and host characteristics in malaria affected travellers returning from AfricaEmanuele Nicastri
Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani, IRCCS, Rome, Italy
Travel Med Infect Dis 6:205-9. 2008..falciparum. The aim of this study was to assess the epidemiological, clinical, host- and parasite-related determinant factor of the genetic diversity of P. falciparum infections in travellers returning to Italy...
Gender differences in clinical progression of HIV-1-infected individuals during long-term highly active antiretroviral therapyEmanuele Nicastri
National Institute for Infectious Diseases, IRCCS L Spallanzani, Rome, Italy
AIDS 19:577-83. 2005..To assess gender differences in the long-term clinical, virological and immunological outcomes during highly active antiretroviral therapy (HAART)...
Human herpesvirus 8 and pulmonary hypertensionEmanuele Nicastri
National Institute for Infectious Diseases IRCCS Lazzaro Spallanzani, Rome, Italy
Emerg Infect Dis 11:1480-2. 2005..No relationship between HHV-8 infection and pulmonary hypertension was found...
HIV-1 residual viremia and proviral DNA in patients with suppressed plasma viral load (<400 HIV-RNA cp/ml) during different antiretroviral regimensEmanuele Nicastri
Istituto Nazionale per le Malattie Infettive IRCCS Lazzaro Spallanzani Rome, Italy
Curr HIV Res 6:261-6. 2008..The better virological performance of NNRTI in terms of low residual viremia is consistent with specific literature data, whereas the greater impact of PI on the viral reservoirs is noteworthy and needs further investigations...
High prevalence of M184 mutation among patients with viroimmunologic discordant responses to highly active antiretroviral therapy and outcomes after change of therapy guided by genotypic analysisEmanuele Nicastri
Department of Public Health, University of Rome Tor Vergata, Rome, Italy
J Clin Microbiol 41:3007-12. 2003..A relationship between the M184V mutation and a viroimmunologic discordant response to HAART was found. After the genotypic analysis-driven change of therapy, similar rates of virologic suppression were detected in the two groups...
Clinical outcome after 4 years follow-up of HIV-seropositive subjects with incomplete virologic or immunologic response to HAARTEmanuele Nicastri
National Institute of Infectious Diseases, IRCCS L. Spallanzani, Rome, Italy
J Med Virol 76:153-60. 2005..001). After 4 years of HAART, the risk of clinical progression in patients with immunologic only or virologic only response is low but still higher than in complete responder patients...
Residual viraemia in subjects with chronic HIV infection and viral load < 50 copies/ml: the impact of highly active antiretroviral therapyLucia Palmisano
Istituto Superiore di Sanita, Department of Drug Research and Evaluation, Rome, Italy
AIDS 19:1843-7. 2005..To determine factors associated with < 2.5 copies/ml plasma HIV RNA in subjects treated with highly active antiretroviral therapy (HAART) and with viraemia < 50 copies/ml...
Drug-associated resistance mutations in plasma and peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected patients for whom highly active antiretroviral therapy is failingLoredana Sarmati
Department of Public Health, University of Rome Tor Vergata, Rome, Italy
J Clin Microbiol 41:1760-2. 2003..85). The mutations with the lowest agreement were 20R, 63P, and 84V in the protease gene and 184V in the reverse transcriptase gene. In eight patients, primary drug resistance mutations were detected only in PBMCs...
Non-B HIV type 1 subtypes: replicative capacity and response to antiretroviral therapyEmanuele Nicastri
National Institute of Infectious Diseases, IRCCS L. Spallanzani, Rome, Italy
AIDS Res Hum Retroviruses 20:816-8. 2004
Replication capacity, biological phenotype, and drug resistance of HIV strains isolated from patients failing antiretroviral therapyEmanuele Nicastri
National Institute of Infectious Diseases, IRCCS L. Spallanzani, Rome, Italy
J Med Virol 69:1-6. 2003..In patients failing HAART, the detection of HIV isolates with the R5 biological phenotype correlates with CD4+ cell count, an impaired replication capacity, and a high number of drug-resistance mutations...
Viral growth assay to evaluate the replicative capacity of HIV-1 isolatesEmanuele Nicastri
National Institute of Infectious Diseases, IRCCS L. Spallanzani, Rome, Italy
J Virol Methods 115:199-205. 2004..A viral assay to evaluate the HIV replicative capacity is described. The high variability of replicative capacity confirms the need to undertake replicative capacity assay using the whole virus...
Antiretroviral therapeutic drug monitoring in HIV-infected pregnant women: maternal immunovirological outcome at delivery and during the 18 month follow-up periodEmanuele Nicastri
Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani, Roma, Italy
Curr HIV Res 10:606-13. 2012..Evaluation of the clinical impact of the low plasma ARV concentrations during pregnancy on the long-term virological outcome deserves further larger studies...
Effect of suppressing HIV viremia on the HIV progression of patients undergoing a genotype resistance test after treatment failureM Zaccarelli
Clinical Department, National Institute for Infectious Diseases Lazzaro Spallanzani, Via Portuense 292, 00149, Rome, Italy
Infection 37:203-9. 2009..To assess the role of viral suppression on clinical progression following a genotypic resistance test (GRT), we have examined a database on patients failing to respond to combined antiretroviral therapy (cART)...
Brief summary of the legal proceedingEmanuele Nicastri
National Institute for Infectious Diseases - IRCCS, Rome, Italy
Scand J Infect Dis Suppl 35:105-7. 2003..The degree of concordance of genotypic assays among 12 experienced laboratories is also reported...
Cellular HIV-1 DNA quantitation in patients during simplification therapy with protease inhibitor-sparing regimensLoredana Sarmati
Department of Public Health and Cellular Biology, University of Rome Tor Vergata, Rome, Italy
J Med Virol 79:880-6. 2007..In addition, sustained suppression of the plasma viral load was significantly correlated with low levels of proviral DNA before treatment simplification...
Decrease of methicillin resistant Staphylococcus aureus prevalence after introduction of a surgical antibiotic prophylaxis protocol in an Italian hospitalEmanuele Nicastri
National Institute for Infectious Diseases, IRCCS Lazzaro Spallanzani, Via Portuense 292 00149, Rome, Italy
New Microbiol 31:519-25. 2008..026). In our experience, the reduction of 3rd generation cephalosporin use was an effective strategy to reduce the MRSA infection rate and was associated with the reduction of the overall expenditure for antibiotics in the hospital...
Discordant response to antiretroviral therapy: HIV isolation, genotypic mutations, T-cell proliferation and cytokine productionGabriella d'Ettorre
Department of Infectious and Tropical Diseases, La Sapienza University, Rome, Italy
AIDS 16:1877-85. 2002..To study virologic and immunologic factors associated with discordant treatment response in HIV-infected patients receiving highly active antiretroviral therapy (HAART)...
Molecular diagnosis and species identification of imported malaria in returning travellers in ItalyMaria Grazia Paglia
National Institute for Infectious Diseases IRCCS Lazzaro Spallanzani, Via Portuense 292, 00149 Rome, Italy
Diagn Microbiol Infect Dis 72:175-80. 2012....
Use of genotypic assays for the detection of HIV antiretroviral resistanceEmanuele Nicastri
Department of Epidemiology, National Institute for Infectious Diseases, L. Spallanzani' IRCCS, Rome, Italy
Scand J Infect Dis Suppl 35:24-8. 2003..Randomized clinical trials to allow general recommendations for the use of resistance assays in clinical practice are still urgently required...
Effect of raltegravir on the total and unintegrated proviral HIV DNA during raltegravir-based HAARTEmanuele Nicastri
National Institute for Infectious Diseases, IRCCS Lazzaro Spallanzani, Rome, Italy
Antivir Ther 16:797-803. 2011..The aim of the study is to test if raltegravir plasma concentrations can be associated with proviral DNA decline during raltegravir-based salvage therapy...
The legal proceeding on the use of genotypic assays for the detection of HIV antiretroviral resistance in Italy: background and rationale for a consensus conference to establish guidelinesGiuseppe Ippolito
National Institute for Infectious Diseases INMI, Lazzaro Spallanzani, Rome, Italy
Scand J Infect Dis Suppl 106:8-11. 2003....
Nosocomial pulmonary infections in HIV-positive patientsNicola Petrosillo
National Institute for Infectious Disease L Spallanzani, IRCCS, Rome, Italy
Curr Opin Pulm Med 11:231-5. 2005..Nosocomial pulmonary infections (NPI) appear to be more common in patients with acquired immunodeficiency syndrome (AIDS), as a result of the degree of immunosuppression, prior use of antibiotics, and exposure to invasive procedures...
Left thigh phlegmon caused by Nocardia farcinica identified by 16S rRNA sequencing in a patient with Leprosy: a case reportPasquale De Nardo
Lazzaro Spallanzani National Institute for Infectious Diseases IRCCS, Via Portuense 292, Rome, 00149, Italy
BMC Infect Dis 13:162. 2013..However, recent literature is limited. We report a case of left thigh phlegmon caused by N. farcinica that occurred in a patient with Leprosy undergoing treatment with prednisone for leprosy reaction...
Accuracy of indirect haemagglutination and western blot assays for the detection of anti-Schistosoma antibodies in non-severe febrile patients in two Tanzanian hospitalsNazario Bevilacqua
National Institute for Infectious Diseases Lazzaro Spallanzani, Rome, Italy
Scand J Infect Dis 44:453-8. 2012....
Use of novel antiretroviral agents in rescue regimens: a case of early virological failure to raltegravirChiara Tommasi
National Institute for Infectious Diseases, INMI, L Spallanzani, Rome, Italy
Scand J Infect Dis 42:237-9. 2010..We describe the clinical outcome of a heavily antiretroviral-experienced patient who experienced early failure to raltegravir...
Improvement of tuberculosis laboratory capacity on Pemba Island, Zanzibar: a health cooperation projectMaria G Paglia
Microbiology Laboratory, Epidemiology and Clinical Departments, National Institute for Infectious Diseases Lazzaro Spallanzani, Rome, Italy
PLoS ONE 7:e44109. 2012..An advanced TB laboratory can represent a low cost solution to strengthen the TB diagnosis, to provide capacity building and mid-term sustainability...
Transplacental transfer of antiretroviral drugs and newborn birth weight in HIV-infected pregnant womenJelena Ivanovic
National Institute for Infectious Diseases Lazzaro Spallanzani, Rome, Italy
Curr HIV Res 7:620-5. 2009....
Septic Shock after Seasonal Influenza Vaccination in an HIV-Infected Patient during Treatment with Etanercept for Rheumatoid Arthritis: a Case ReportPasquale De Nardo
National Institute for Infectious Diseases L Spallanzani, Rome, Italy
Clin Vaccine Immunol 20:761-4. 2013..We describe a case of septic shock and multiorgan failure that occurred after etanercept initiation and influenza vaccination in an HIV-infected woman with rheumatoid arthritis...
Treatment of Recurrent Hepatocellular Carcinoma with Sorafenib in a HIV/HCV Co-Infected patient in HAART: A Case ReportPasquale De Nardo
Clinical Department of Infectious Diseases, National Institute for Infectious Diseases IRCCS L, Spallanzani, Via Portuense 292, 00149, Rome, Italy
Infect Agent Cancer 7:15. 2012..abstract:..
Viral hemorrhagic fevers: advancing the level of treatmentGiuseppe Ippolito
National Institute for Infectious Diseases Lazzaro Spallanzani, Rome, Italy
BMC Med 10:31. 2012..Here we discuss the current knowledge about VHF clinical management to propose a way to step up the approach to VHFs beyond the mere application of infection control measures...
Seroprevalence of dengue infection: a cross-sectional survey in mainland Tanzania and on Pemba Island, ZanzibarFrancesco Vairo
National Institute for Infectious Diseases, L Spallanzani, Rome, Italy
Int J Infect Dis 16:e44-6. 2012..The objective of this study was to provide seroprevalence data on dengue infection in Tanzania...
Contamination by hepatitis B and C viruses in the dialysis settingNicola Froio
National Institute for Infectious Diseases, Lazzaro Spallanzani, Rome, Italy
Am J Kidney Dis 42:546-50. 2003..Major attention should be given to strict adherence to infection control measures in the dialysis setting...
Healthcare-associated infection in Italy: annual point-prevalence surveys, 2002-2004Simone Lanini
Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani, Roma, Italy
Infect Control Hosp Epidemiol 30:659-65. 2009..Healthcare-associated infections (HAIs) are an important cause of morbidity and mortality worldwide. During the period from 2002 through 2004, a group of Italian hospitals was recruited to conduct HAI point-prevalence surveys...
Incidence and risk factors associated with pressure ulcers among patients with HIV infectionEmanuele Nicastri
National Institute for Infectious Diseases, L. Spallanzani, IRCCS, Rome, Italy
Adv Skin Wound Care 17:226-31. 2004..Aggressive preventive strategies should be implemented to decrease the complications associated with pressure ulcers among patients infected with HIV-1...
Marked increase in etravirine and saquinavir plasma concentrations during atovaquone/proguanil prophylaxisChiara Tommasi
National Institute for Infectious Diseases L, Spallanzani, Via Portuense 292, 00149 Rome, Italy
Malar J 10:141. 2011..The evidence that atovaquone/proguanil significantly interacts with etravirine and saquinavir, but not with raltegravir and maraviroc, suggests that the mechanism of interaction is related to cytochrome P450...
Methicillin-resistant Staphylococcus aureus: the superbugGiuseppe Ippolito
National Institute for Infectious Diseases Lazzaro Spallanzani, Via Portuense 293, 00149 Rome, Italy
Int J Infect Dis 14:S7-11. 2010..This review will briefly discuss the epidemiology, costs, outcome, and therapeutic options for the management of MRSA infections...
Consensus document on controversial issues in the diagnosis and treatment of bloodstream infections and endocarditisEvangelo Boumis
Istituto Nazionale per le Malattie Infettive, I R C C S Lazzaro Spallanzani, Roma, Italy
Int J Infect Dis 14:S23-38. 2010..The GRADE method for grading the quality of evidence and strength of recommendation was applied...
Nosocomial bloodstream infections among human immunodeficiency virus-infected patients: incidence and risk factorsNicola Petrosillo
Istituto Nazionale per le Malattie Infettive L Spallanzani, Istituto di Ricovero e Cura a Carattere Scientifico, 00149 Rome, Italy
Clin Infect Dis 34:677-85. 2002..6% and 7.2% among patients with and without NBSIs, respectively (P<.00001). In the era of highly active antiretroviral therapy, NBSIs continue to occur frequently and remain severe and life-threatening manifestations...
Plasma HIV RNA decline and emergence of drug resistance mutations among patients with multiple virologic failures receiving resistance testing-guided HAARTValerio Tozzi
National Institute for Infectious Diseases Lazzaro Spallanzani, 00149 Rome, Italy
AIDS Res Hum Retroviruses 24:787-96. 2008..In contrast, early changes in PVL levels were not. Virologic failure was associated with detection of emergent DRMs. Virologic rebound in patients on salvage-HAART should be addressed aggressively...
Surgical site infections in plastic surgery: an italian multicenter studyCecilia M J Drapeau
National Institute for Infectious Diseases L Spallanzani, Rome, Italy
J Surg Res 143:393-7. 2007..The aim of the present study was to assess the SSI frequency in plastic and reconstructive surgery settings in Italy and to evaluate the associated risk factors...
Sonographic assessment of facial HIV-related lypoatrophyAda Petrone
Diagnostic Department, Radiology, National Institute for Infectious Diseases, Rome, Italy
Dermatol Surg 35:1066-72. 2009..To investigate the utility of ultrasonography (US) for assessing and grading facial lypoatrophy (FLA) in patients with HIV...
Resistant and multi-resistant Gram-positive severe infections: the GISIG working methodologyFrancesco N Lauria
National Institute for Infectious Diseases L Spallanzani, Rome, Italy
Int J Infect Dis 14:S13-7. 2010..The working groups reviewed the available studies and formulated recommendations to be voted on at the national consensus conference held in Rome in June 2009...
A nosocomial and occupational cluster of hepatitis A virus infection in a pediatric wardNicola Petrosillo
National Institute for Infectious Diseases, Lazzaro Spallanzani, IRCCS, Rome, Italy
Infect Control Hosp Epidemiol 23:343-5. 2002..An interview with the unit personnel revealed several breaches in infection control measures and the lack of vaccination of healthcare workers against HAV ...
Initial treatment of HIV-1 infectionEmanuele Nicastri
N Engl J Med 359:970-1; author reply 971. 2008
Prevalence trend and correlates of HHV-8 infection in HIV-infected patientsSaverio Giuseppe Parisi
Institute of Immunology and Infectious Diseases, University of Verona, Italy
J Acquir Immune Defic Syndr 29:295-9. 2002..In conclusion, HHV-8 seroprevalence appears to be increased during 10 years among HIV-infected injection drug users but not among homosexual men, who remain those at the highest risk of infection...
The legal proceeding: introduction of the witnessesEmanuele Nicastri
National Institute for Infectious Diseases - IRCCS Lazzaro Spallanzani, Via Portuense 292, 00149 Rome, Italy
Scand J Infect Dis Suppl 35:58-60. 2003
Discordance between genotypic and phenotypic drug resistance profiles in human immunodeficiency virus type 1 strains isolated from peripheral blood mononuclear cellsLoredana Sarmati
Department of Public Health, University of Rome Tor Vergata. IRCCS L. Spallanzani, Italy
J Clin Microbiol 40:335-40. 2002..Despite the low number of patients and the short follow-up period, this study suggests that during failing therapy with analogue nucleosides, a phenotypic analysis could be performed in spite of an HIV genotypic sensitivity pattern...
Association between cellular human immunodeficiency virus DNA level and immunological parameters in patients with undetectable plasma viremia level during highly active antiretroviral therapyLoredana Sarmati
Department of Public Health and Cellular Biology, University of Tor Vergata, Via Montpellier 1, 00133 Rome, Italy
J Clin Microbiol 43:6183-5. 2005..005) CD4 counts and a prolonged duration of treatment (P = 0.001). At adjusted analysis, prolonged duration of treatment was independently associated with lower (P = 0.006) and undetectable (P < 0.001) HIV DNA values...
Primary human herpesvirus 8 infection in immunocompetent childrenMassimo Andreoni
Department of Public Health and Cellular Biology, University Tor Vergata, Via Montpellier 1, 00133 Rome, Italy
JAMA 287:1295-300. 2002..Human herpesvirus 8 (HHV-8) infection causes Kaposi sarcoma and lymphoproliferative disorders in immunosuppressed adults. Its manifestations in immunocompetent hosts are unknown...
Human herpesvirus 8 cytoviraemia rebound in a patient with Kaposi's sarcoma after a short interruption of efficient antiretroviral therapySaverio Giuseppe Parisi
AIDS 16:1089-91. 2002
Human immunodeficiency virus polymorphisms and zidovudine resistanceEmanuele Nicastri
Antimicrob Agents Chemother 47:2714; author reply 2714-5. 2003
Reply to "Different degree of immune recovery using antiretroviral regimens with protease inhibitors or non-nucleosides", by Barreiro et alEmanuele Nicastri
AIDS 17:447-8. 2003
Stavudine protective function and emergence of Lamivudine resistanceEmanuele Nicastri
Antimicrob Agents Chemother 47:1176; author reply 1176. 2003
[Cases of Chikungunya fever in Italy in travellers returning from the Indian Ocean and risk of introduction of the disease to Italy]Francesco Maria Fusco
Dipartimento di Ricerca Sperimentale, INMI L. Spallanzani, Roma, Italy
Infez Med 14:238-45. 2006..We describe 7 cases of Chikungunya fever imported into Italy by travellers returning from affected countries. The current outbreak is described, and the risk of establishment of a chain of transmission in Italy is discussed...
[Severe acute respiratory syndrome: the first transmissible disease of the 21st century]Emanuele Nicastri
II Divisione, Istituto Nazionale per le Malattie Infettive IRCCS Lazzaro Spallanzani, Roma
Recenti Prog Med 94:295-303. 2003..The spread of SARS, to less developed country with limited resource for public health programs, represent the emerging alarming threat in the new global scenario...
Eight days vs 15 days of antibiotics for ventilator-associated pneumoniaEmanuele Nicastri
JAMA 291:820; author reply 820. 2004
Eosinophilic meningitis in a returned traveler from Santo Domingo: case report and reviewSebastiano Leone
Department of Infectious Diseases, Second University of Naples, Naples, Italy
J Travel Med 14:407-10. 2007..Treatment with mebendazole and steroids was effective. The presence of persistent headache, fever, and eosinophilia in travelers who return from developing countries should alert clinicians to the possibility of EM...
SARS and the removal of personal protective equipmentVincenzo Puro
CMAJ 170:930. 2004
Stopping antiretroviral therapy: role for therapeutic drug monitoringChiara Tommasi
AIDS 22:315-6. 2008
